(Q45868947)

17 December 2017

title

Practice patterns in haemophilia A therapy--a survey of treatment centres in the United States (English)

1 reference

17 December 2017

Practice patterns in haemophilia A therapy – a survey of treatment centres in the United States (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

14 March 2024

0 references

0 references

United States of America

0 references

author name string

Wilma McClure

2

1 reference

17 December 2017

Karen Wulff

3

1 reference

17 December 2017

Regina B. Butler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511293

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511293

14 March 2024

publication date

1 September 2003

1 reference

17 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2516.2003.00792.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.2003.00792.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

14 March 2024

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

549-554

1 reference

17 December 2017

The impact of prophyactic treatment on children with severe haemophilia

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Product choice and haemophilia treatment in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

The orthopaedic status of severe haemophiliacs in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Complications experienced with central venous catheters in children with congenital bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

A prospective clinical trial of implantable central venous access in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

The use of central venous catheters (portacaths) in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Barriers to compliance with prophylaxis therapy in haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00792.X

Modern treatment of haemophilia

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

Results of secondary prophylaxis in children with severe hemophilia

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

Implantable venous access devices in children with hemophilia: a report of low infection rates

14 March 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00792.X

14 March 2024

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017